Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy
Despite diagnosis, <10% initiated treatment within 5 years of RNA positivity and multiple pregnancies occurred before treatment, resulting in repeated exposures. Additional efforts will be required to ensure linkage-to-care and treatment either during pregnancy or postpartum.
Authors
- William W. L. Wong (ORCID: https://orcid.org/0000-0003-4630-0052)
- Camelia Capraru
- Jennifer A. Flemming (ORCID: https://orcid.org/0000-0002-9911-0925)
- Chelsea Masterman
- Andrew Mendlowitz (ORCID: https://orcid.org/0000-0002-0178-5087)
- Mia J. Biondi (ORCID: https://orcid.org/0000-0002-1409-9908)
- Zoë R. Greenwald (ORCID: https://orcid.org/0000-0001-7942-3951)
- Jordan J. Feld (ORCID: https://orcid.org/0000-0003-2640-2211)
- Tatyana Kushner (ORCID: https://orcid.org/0000-0001-6663-6253)
- Jeffrey C. Kwong (ORCID: https://orcid.org/0000-0002-7820-2046)
- Bo Chen (ORCID: https://orcid.org/0000-0002-9926-4377)
- Wenbin Li
Institutions
- Western University (CA)
- University Health Network (CA)
- 3M (United States) (US)
- University of Waterloo (CA)
- Hult International Business School (GB)
- Toronto Public Health (CA)
- University of Toronto (CA)
- York University (CA)
- Queen's University (CA)
- Cornell University (US)
- Public Health Ontario (CA)
- St Michael’s Hospital (GB)
- Institute for Clinical Evaluative Sciences (CA)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1093/cid/ciaf578
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gilead Sciences
- Cancer Care Ontario
- Public Health Agency of Canada
- Public Health Agency
- National Institutes of Health
- Canadian Institutes of Health Research